Yu Jing, Yang Xue, Wu Hongmei, Li Jiansheng
Department of Abdominal Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao 266000, China.
J Oncol. 2021 Jul 28;2021:2380958. doi: 10.1155/2021/2380958. eCollection 2021.
To investigate the clinical significance of color ultrasound, magnetic resonance imaging (MRI), miR-21, and CA199 in the diagnosis of pancreatic cancer (PC).
A total of 160 patients with PC admitted to our hospital from April 2018 to February 2021 were included in the PC group, and another 100 patients with benign pancreatic disease during the same period were included in the pancreatic benign disease group. Color ultrasound and MRI were used for imaging examination of the two groups of PC patients, and the sensitivity, accuracy, and specificity of the two methods for preoperative diagnosis of PC were calculated, respectively. A total of 100 healthy people who underwent physical examination during the same period were included in the control group. Serum CA199 levels of the three groups were detected by ELISA assay. The level of serum miR-21 in the three groups was detected by qRT-PCR. A receiver operating curve (ROC) was drawn to analyze and calculate the sensitivity, specificity, and accuracy of the two serum markers and the combination of color ultrasound and MRI in the detection of PC.
Serum CA199 and miR-21 levels in the PC group were significantly higher than those in the benign lesion group and control group. CA199 and miR-21 levels in the benign lesion group were higher than those in the control group. Both color ultrasound and MRI showed a higher detection rate for PC, and the sensitivity and accuracy were significantly higher than those of CA199 and miR-21. The sensitivity, specificity, and accuracy of combined detection were 91.88%, 96.00%, and 93.46%, respectively, which were significantly higher than those of single detection.
The combined detection of color ultrasound, MRI, miR-21, and CA199 have a high application value in the early diagnosis of PC, which can effectively improve the sensitivity and accuracy of clinical diagnosis, reduce the probability of missed diagnosis and misdiagnosis, and provide a reference for the rational clinical treatment plan and prognosis.
探讨彩色超声、磁共振成像(MRI)、miR-21和CA199在胰腺癌(PC)诊断中的临床意义。
选取2018年4月至2021年2月我院收治的160例PC患者作为PC组,同期选取100例胰腺良性疾病患者作为胰腺良性疾病组。对两组PC患者采用彩色超声和MRI进行影像学检查,分别计算两种方法对PC术前诊断的灵敏度、准确性和特异性。同期选取100例健康体检者作为对照组。采用ELISA法检测三组血清CA199水平。采用qRT-PCR法检测三组血清miR-21水平。绘制受试者工作特征曲线(ROC),分析计算两种血清标志物以及彩色超声与MRI联合检测PC的灵敏度、特异性和准确性。
PC组血清CA199和miR-21水平显著高于良性病变组和对照组。良性病变组CA199和miR-21水平高于对照组。彩色超声和MRI对PC的检出率均较高,灵敏度和准确性显著高于CA199和miR-21。联合检测的灵敏度、特异性和准确性分别为91.88%、96.00%和93.46%,显著高于单项检测。
彩色超声、MRI、miR-21和CA199联合检测在PC早期诊断中具有较高的应用价值,可有效提高临床诊断的灵敏度和准确性,降低漏诊和误诊概率,为合理制定临床治疗方案及判断预后提供参考。